Celiac Disease Market Key Players Analysis - Amgen, Anokion SA, BioLineRx Ltd, ChemoCentryx, Inc, COUR Pharmaceutical, F.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Celiac Disease Market Size, Share & Trends Analysis Report By Treatments (Infliximab, Larazotide Acetate, Gluten Free Diet), Route Of Administration (Oral And Parenteral), End-Users (Hospitals, Homecare), And Distribution Channels (Hospital Pharmacy, Online Pharmacy, And Retail Pharmacy), Region, Market Outlook And Industry Analysis 2031"

The Global Celiac Disease Market is estimated to reach over USD 1,195.5 Mn by 2031, exhibiting a CAGR of 9.8% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2874

Celiac disease is an autoimmune condition in which a protein called gluten destroys the small intestinal membrane. Gluten can be found in cereals like rye, barley, and wheat. Gluten triggers an immune response that destroys the villi in the small intestine. The damage reduces the body's ability to absorb proteins, nutrients, lipids, vitamins, carbohydrates, and minerals. This ultimately leads to malnutrition. The Celiac Disease Market is expanding rapidly as knowledge grows, diagnostic skills improve, and the disease's prevalence rises. The industry is seeing trends such as increased awareness and diagnosis, growth in the gluten-free product market, and research and development of therapy options. Key causes include the rising prevalence of celiac disease, greater diagnostic capabilities, and the increased popularity of gluten-free diets.

However, challenges such as low awareness and underdiagnosis, as well as strict gluten-free rules, must be addressed. Market segmentation based on diagnostic tests, treatment choices, end users, and location enables targeted tactics and tailored solutions. To fulfill the increased demand and enhance patient outcomes, important stakeholders can offer breakthrough diagnostic tests, medicines, and gluten-free products. The Celiac Disease Market is predicted to expand further, owing to rising awareness and attention on the treatment of this chronic autoimmune illness.

List of Prominent Players in the Celiac Disease Market:
• Amgen
• Anokion SA
• BioLineRx Ltd
• ChemoCentryx, Inc
• COUR Pharmaceutical
• F. Hoffmann-La Roche Ltd
• ImmunogenX, LLC
• Innovate Biopharmaceuticals
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceutical Industries Ltd.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02

Market Dynamics:
Drivers-
The driving factors of this market are several key factors. One is the ever-increasing prevalence of celiac disease, which creates a greater demand for gluten-free products and therapies in general. Another factor is growing consumer awareness about the health implications of consuming gluten. Although most people with this type of disease are diagnosed with the disease, others who are not even diagnosed are adopting gluten-free diets because of growing consumer awareness of the adverse health effects of consuming gluten. Moreover, improvement in diagnostic techniques is resulting in proper and earlier detection of the disease, thereby increasing the patient population. The availability of gluten-free products in supermarkets and restaurants is also increasing because more patients are obtaining a gluten-free diet prescription, thus making it easier for patients to follow their restricted dietary regime, further fueling market growth.

Challenges:
The celiac disease market has several restraints that may impede its growth. First, gluten-free products come with quite a hefty price tag, hence limiting access to most patients and their families. Underdiagnosis may also be prevalent due to limited knowledge or awareness about celiac disease in various regions. Additionally, labeling and safety regulations concerning food products are extremely tight, thus posing various difficulties in the functioning of manufacturers manufacturing gluten-free products. Lastly, because gluten-free products are fewer, not as widely sold in developing countries, and sold less frequently, it is difficult, in some regions, to expand the market and also ensure that patients follow prescriptions and guidelines given by doctors.

Regional Trends:
The North American Celiac Disease market dominates the celiac disease treatment market due to the increasing prevalence of celiac illness, the availability of key market participants, and the increase in refined healthcare spending in the North American area. The United States is the largest donor to celiac disease treatment. In addition, the Asia-Pacific Celiac Disease Market is predicted to rise at a quick CAGR between 2023 and 2032. This is attributed to increased disease awareness and population growth in the region. Furthermore, China's Celiac Disease Treatment market had the greatest market share, while India's Celiac Disease Treatment market was the fastest expanding in the Asia-Pacific region.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2874

Recent Developments:
• In June 2021, BioLineRx announced the start of a Phase 2b clinical trial for its flagship drug, BL-7010, as a therapy for celiac disease. The experiment will assess the safety and efficacy of BL-7010 in lowering gluten-induced symptoms and gut inflammation in celiac disease patients.
• In September 2022, ChemoCentryx recently announced encouraging results from a Phase 2 clinical trial of a new medication candidate for celiac disease-associated refractory sprue. The study found that refractory sprue, a severe form of celiac disease, showed encouraging results in terms of symptom reduction and intestinal health.

Segmentation of Celiac Disease Market-
By Treatments-
• Infliximab
• Larazotide Acetate
• Gluten-Free Diet
• Others
By Route of Administration-
• Oral
• Parenteral
By End-Users-
• Hospitals
• Homecare
• Others
By Distribution Channels-
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/2874

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.